聚合搜Scholar - 壹搜网为您找到"

英伟达ai课程

"相关结果 10条

What Nourishes Us: Psychometric Validation of Culturally Grounded Measures of Indigenous Nourishment in a Cross-Sectional Study of 2 Urban Native Communities.

To examine the Indigenous Nourishment Scales (INS), a set of community-developed strengths-based measures of nourishment, for psychometric validity and reliability through community-based research with two urban American Indian/Alaska Native (AI/AN) communities.
www.ncbi.nlm.nih.gov

Development and application of an ANN-perception-based autonomous control system for

To address the challenges of overflow metabolism and the heavy reliance on manual intervention in high-density
www.ncbi.nlm.nih.gov

Rosamultin Alleviates LPS-Induced Acute Kidney Injury by Promoting Autophagy and Inhibiting the NF-κB Signaling Pathway.

Rosamultin (RS), a triterpenoid compound, is the main active component of the traditional Dong ethnic medicine "Madeng'ai". It has been proven to have a significant therapeutic effect on improving renal fibrosis. However, the potential role of RS in the treatment of acute kidney injury (AKI) and the underlying molecular mechanisms remain unclear. Therefore, this study investigates whether RS confers renal protection in AKI and seeks to elucidate its underlying mechanisms.
www.ncbi.nlm.nih.gov

Efficacy and Safety of Finerenone Combined with Dapagliflozin in the Treatment of Non-Diabetic Chronic Kidney Disease: A Single-Center Retrospective Study.

The combination of non-steroidal mineralocorticoid receptor antagonists (nsMRAs) and sodium-glucose cotransporter-2 (SGLT2) inhibitors has shown renoprotective benefits in diabetic kidney disease; however, their synergistic effects in non-diabetic chronic kidney disease (CKD) remain underexplored. This study evaluated the efficacy and safety of finerenone combined with dapagliflozin versus dapagliflozin monotherapy in patients with non-diabetic CKD.
www.ncbi.nlm.nih.gov

Targeted Degradation of Histone Deacetylase 8 Using Proteolysis Targeting Chimeras Technology: A Promising Approach for Glioblastoma Treatment.

Histone deacetylase 8 (HDAC8) plays a role in glioblastoma progression, making it a promising therapeutic target. While HDAC8 inhibitors (HDAC8is) suppress glioblastoma growth and prolong survival in animal models, they do not eliminate HDAC8. In contrast, HDAC8-targeting proteolysis-targeting chimera (PROTAC), a selective HDAC8 degrader, induces proteasomal degradation of HDAC8 and thus eliminates all of its functions.
www.ncbi.nlm.nih.gov